KMTS Company Profile and Key Details

NASDAQ : KMTS

KESTRA MEDICAL TECHNOLOGIES LTD

$20.72

1.46+7.58%

Open: 11:57 AM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) stock surged +7.58%, trading at $20.72 on NASDAQ, up from the previous close of $19.26. The stock opened at $19.35, fluctuating between $19.35 and $20.78 in the recent session.

Stock Snapshot

19.26

Prev. Close

1.21B

Market Cap

19.35

Day Low

-5.18

P/E Ratio

-4

EPS (TTM)

N/A

Cash Flow per Share

19.35

Open

58.35M

Number of Shares

20.78

Day High

46.53%

Free Float in %

N/A

Book Value

151.13K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 16, 2026	19.17	20.01	18.71	19.26	537.65K
Mar 13, 2026	19.10	19.82	17.69	19.08	742.39K
Mar 12, 2026	21.68	22.12	18.53	19.02	619.12K
Mar 11, 2026	22.18	22.45	21.78	22.14	324.27K
Mar 10, 2026	23.13	23.54	21.95	22.29	433.78K
Mar 09, 2026	22.98	24.71	22.55	23.44	453.64K
Mar 06, 2026	23.11	23.66	22.67	23.04	245.08K
Mar 03, 2026	22.17	23.36	22.17	22.92	493.66K
Mar 02, 2026	22.92	23.48	22.21	22.75	259.3K
Feb 27, 2026	24.14	24.83	22.85	23.28	188.49K
Feb 26, 2026	25.12	25.41	23.95	24.55	182.24K
Feb 25, 2026	26.57	27.41	25.17	25.25	193.8K
Feb 24, 2026	26.68	27.33	26.20	26.34	179.41K
Feb 23, 2026	26.56	27.28	25.88	26.69	195.09K
Feb 20, 2026	26.20	27.25	25.52	26.56	195.48K
Feb 19, 2026	25.36	26.49	24.39	26.32	271.51K
Feb 18, 2026	25.79	26.35	24.49	25.55	219.76K
Feb 17, 2026	26.68	27.17	24.75	26.08	420.39K
Feb 13, 2026	27.65	28.19	25.73	26.92	539.33K
Feb 12, 2026	27.93	28.04	26.98	27.46	218.87K

Contact Details

Kirkland, WA 98033

United States

https://kestramedical.com 425 279 8002

About Company

Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. Its Cardiac Recovery System platform is the ASSURE WCD, a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). The company's Cardiac Recovery System platform also includes a suite of integrated digital solutions and services that enable enhanced patient and provider engagement and oversight with the objective of improving patient outcomes. The company was founded in 2014 and is based in Kirkland, Washington.

Stock Peers

ISRG

11.3+2.39%

Intuitive Surgical, Inc.$483.46 ATRI

0.26+0.06%

Atrion Corporation$459.92 MASI

-0.09-0.05%

Masimo Corporation$175.40 ICUI

1.11+0.88%

ICU Medical, Inc.$126.96 RGEN

0.91+0.80%

Repligen Corporation$115.11 LMAT

2.69+2.49%

LeMaitre Vascular, Inc.$110.75 HOLX

0.03+0.04%

Hologic, Inc.$75.15 COO

1.12+1.60%

The Cooper Companies, Inc.$71.04 MMSI

-0.775-1.11%

Merit Medical Systems, Inc.$69.17 UTMD

0.72+1.14%

Utah Medical Products, Inc.$64.00

Company Overview

KESTRA MEDICAL TECHNOLOGIES, LTD. (NASDAQ:KMTS) closed at $20.72 USD, gaining $1.46 (7.58%) from the previous close of $19.26. The stock is currently mid-range between its 52-week high and low $13.25 and $30.00. With a market capitalization of about $1.21 billion, KESTRA MEDICAL TECHNOLOGIES, LTD. is classified as a small-cap and shows lower-than-market volatility (beta ~0.17). Key stats such as the average daily volume over the past year has been around 300.32 thousand shares, volume is running light vs its 52-week average. Headquartered in Kirkland, WA, KESTRA MEDICAL TECHNOLOGIES, LTD. operates in the Healthcare sector and the Medical - Instruments & Supplies industry. Led by CEO Brian Webster, the company employs approximately 300 people and listed since March 06, 2025. Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company.

Technical Performance

KMTS has shown weak momentum, losing -1.75% over the past week and -6.54% over the past quarter, though year-to-date performance is down -13.27%. Short-term trend indicators are bearishly aligned (SMA20 -5.47%, SMA50 -4.23%, SMA200 10.63%). The stock’s 14-day RSI is 41.88 (neutral), while the ATR of 1.65 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -18.17% below its high and over 85.28% above its low. Average 10-day trading volume of 518.48 thousand shares is significantly above the 3-month average of 291.63 thousand, indicating heightened recent market interest.

Valuation Metrics

KESTRA MEDICAL TECHNOLOGIES, LTD. trades at a P/E ratio of -7.47, slightly below the S&P 500 average, with a price-to-sales ratio of 15.1 and a price-to-book ratio of 6.02 trading at moderately above to book value. The P/FCF stands at -9.82, also below market averages.

Dividend & Fair Value

KESTRA MEDICAL TECHNOLOGIES, LTD. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$22.50. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

Wall Street analysts project EPS growth of 31.93% annually over the next five years. Analyst sentiment is bullish. Analyst rating data shows there are 6 Strong Buy ratings, 2 Buy ratings, 2 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $32.00 to $24.00. The high target offers 66.15% upside. The low target suggests 24.61% downside. The mean target is $27.80. This offers 44.34% upside. KESTRA MEDICAL TECHNOLOGIES, LTD. earnings surprise history is a mixed track record. The quarter that ended December 11, 2025, missed forecasts by 10.71%. The prior quarter beat by -30.3%. Over the last six quarters, Apple has recorded several small beats. These include -30.3% in September 11, 2025.

Shareholding & Insider Activity

KESTRA MEDICAL TECHNOLOGIES, LTD. has 51.35 million shares outstanding. The public float is 3.98 million shares, elevated short interest at 8.68% of float. This equals 2.07 million shares. The short ratio is 5.01 days. Institutional investors hold 100.78% of the float. Insiders own 6.44%. Webster Brian Daniel holds 379.79 thousand shares, Umberger Traci S has 136.63 thousand shares and Ford Alfred J Jr has 49.41 thousand shares. Over the past six months, insider transactions show net selling. They sold 40.59 thousand shares across 4 transactions.

Financial & Profitability Overview

Over the trailing twelve months, KESTRA MEDICAL TECHNOLOGIES LTD generated $59.82M in revenue, or $1.21 per share. Gross margin was 40.47%, operating margin -177.85%, and net profit margin -190.28%. Returns are negative, with ROA at -38.48% and ROE at -55.41%.
On valuation metrics, KESTRA MEDICAL TECHNOLOGIES LTD trades at a P/E of -7.47, P/S of 15.10 and P/B of 6.02. The current ratio is 5.47 and quick ratio is 5.47. Operationally, the company’s inventory turnover is 0.00 and cash conversion cycle is -134.13 days , indicating it collects cash faster than it pays suppliers. Debt-to-equity is 0.02, supported by a cash flow-to-debt ratio of -29.62.

Quarterly Financial Highlights

Gross profit was $24.21M (margin 40.47%). Operating income was - $106.38M (margin -177.8%). Net income was- $113.81M (EPS - $5.13).
The company ended the quarter with $237.60M in cash and short-term investments, a total debt of $44.31M, and net debt of - $193.28M. Total assets were $295.74M, with equity of $205.41M. Financials further reflected weakness, with operating cash flow of - $77.61M, free cash flow of - $101.20M, and capital expenditures of - $23.59M.

Price Forecast & Outlook

Our AI price prediction model suggests that KESTRA MEDICAL TECHNOLOGIES, LTD. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -18.28%, with price expected at $15.74 by March 30, 2026, within a range of $14.57 to $16.75 3-Month Outlook: Projected fall of -22.38%, reaching $14.95 by June 12, 2026, with a range of $14.50 to $15.36. 1-Year Outlook: Projected gain of 17.86%, with price at $22.70 by March 16, 2027, within a range of $21.34 to $23.94.

Key Takeaways

KESTRA MEDICAL TECHNOLOGIES, LTD. (NASDAQ:KMTS) shares are down -13.27% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows KESTRA MEDICAL TECHNOLOGIES, LTD. trading at a premium to the broader market with a P/E of -7.47. Analyst sentiment is mixed, with the majority of ratings in Neutral territory and a mean price target of $27.80, suggesting 44.34% upside. Our AI forecast model points to short-term weakness (-18.28% over two weeks), a medium-term fall (-22.38% over three months), and a longer-term gain (17.86% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) stock price?

KESTRA MEDICAL TECHNOLOGIES, LTD. (NASDAQ: KMTS) stock price is $20.72 in the last trading session. During the trading session, KMTS stock reached the peak price of $20.78 while $19.35 was the lowest point it dropped to. The percentage change in KMTS stock occurred in the recent session was 7.58% while the dollar amount for the price change in KMTS stock was $1.46.

KMTS's industry and sector of operation?

The NASDAQ listed KMTS is part of Medical - Instruments & Supplies industry that operates in the broader Healthcare sector. KESTRA MEDICAL TECHNOLOGIES, LTD. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of KMTS?

No Data

How KMTS did perform over past 52-week?

KMTS's closing price is 45.36% higher than its 52-week low of $13.25 where as its distance from 52-week high of $30.00 is -35.8%.

How many employees does KMTS have?

Number of KMTS employees currently stands at 300.

Link for KMTS official website?

Official Website of KMTS is: https://kestramedical.com

How do I contact KMTS?

KMTS could be contacted at phone 425 279 8002 and can also be accessed through its website. KMTS operates from 3933 Lake Washington Blvd NE, Kirkland, WA 98033, United States.

How many shares of KMTS are traded daily?

KMTS stock volume for the day was 151.13K shares. The average number of KMTS shares traded daily for last 3 months was 300.32K.

What is the market cap of KMTS currently?

The market value of KMTS currently stands at $1.21B with its latest stock price at $20.72 and 58.35M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	300
Beta	0.17
Sales or Revenue	$59.82M
5Y Sales Change%	0%
Fiscal Year Ends	April
Sector	Healthcare
Industry	Medical - Instruments & Supplies

KMTS Company Profile and Key Details

KESTRA MEDICAL TECHNOLOGIES LTD

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Earnings & Analyst Outlook

Price Forecast & Outlook

Dividend & Fair Value

Key Takeaways

Company Overview

Valuation Metrics